SCHEMBL2455161

SCHEMBL2455161

Cc1ncn(-c2ccc(Nc3cccn4c(C)c(C)nc34)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 14/20 0.47
MAPK8 P45983 7/20 0.40
JUN P05412 2/20 0.40
CYP3A4 P08684 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
ATP4A P20648 2/20 0.36
ATP4B P51164 2/20 0.36
MAPK13 O15264 3/20 0.35
MAPK12 P53778 3/20 0.35
MAPK11 Q15759 3/20 0.35
MAPK14 Q16539 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2454631 0.79 PSEN1 (0.51) MAPK10MAPK8JUNPSEN1PSEN2
SCHEMBL2453772 0.73 MAPK10 (0.44) MAPK10MAPK8JUNPSEN1PSEN2
Hydrochloric Acid SCHEMBL2454920 0.71 PSEN1 (0.55) MAPK10MAPK8JUNPSEN1PSEN2
SCHEMBL2456340 0.70 PSEN1 (0.45) MAPK10MAPK8JUNPSEN1PSEN2
SCHEMBL2453258 0.69 PSEN1 (0.40) MAPK10MAPK8JUNPSEN1PSEN2
SCHEMBL2456523 0.69 MAPK10 (0.38) MAPK10MAPK8JUNPSEN1PSEN2
SCHEMBL416014 0.69 MAPK10 (0.46) MAPK10MAPK8JUNPSEN1PSEN2
SCHEMBL2456290 0.68 PSEN1 (0.39) MAPK10JUNCYP2C9PSEN1PSEN2
SCHEMBL1360624 0.68 CYP1A2 (0.35) CYP3A4CYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL2453620 0.67 MAPK10 (0.39) MAPK10MAPK8JUNPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379552-B1 SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS JANSSEN PHARMACEUTICALS INC (US) 2014-02-26 EP disclosed
US-8546440-B2 Substituted bicyclic imidazole derivatives as gamma secretase modulators Janssen Pharmaceuticals, Inc. (US) 2013-10-01 US disclosed
US-20110237580-A1 SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS Janssen Pharmaceuticals, Inc. 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237580-A1 SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 MAPK10 4312/4885MAPK8 4231/4885JUN 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.